FDA Drug recall D-0142-2016
TESTOSTERONE CYPIONATE FOR SUBQ INJECTION, Injectable Solution, 100 mg/mL, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional…
- FDA Drug
- Class II
- terminated
- Published 2015-11-04
On 2015-11-04 the FDA classified a Class II recall of TESTOSTERONE CYPIONATE FOR SUBQ INJECTION, Injectable Solution, 100 mg/mL, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional… by Jd And Sn, citing lack of Assurance of Sterility; all sterile human compounded drugs within expiry.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0142-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-24 |
| Published | 2015-11-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Jd And Sn |
| Distribution | US |
Product
TESTOSTERONE CYPIONATE FOR SUBQ INJECTION, Injectable Solution, 100 mg/mL, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
Reason
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Identifiers
| code_info | t12102014@3, t06252015@37 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0142-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.